Search results
Results From The WOW.Com Content Network
Bristol-Myers Squibb (BMY) closed at $60.50 in the latest trading session, marking a -1.59% move from the prior day.
Bristol-Myers Squibb earnings for the second quarter of the year have BMY stock on the move Thursday.Source: Shutterstock Bristol-Myers Squibb (NYSE:BMY) reported earnings per share of $1.18 for ...
Bristol Myers (BMY) delivered earnings and revenue surprises of 2.08% and 3.48%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Bristol-Myers Squibb (BMY) stock is looking quite impressive for momentum-oriented investors as it has favorable price performance and is also seeing positive estimate revisions.
Bristol Myers Squibb (BMY) closed at $75.14 in the latest trading session, marking a -1.42% move from the prior day.
(See BMY stock analysis on TipRanks).On Dec. 15, Goldman Sachs analyst Terence Flynn raised the stock’s price target to $86 (32.4% upside potential) from $82 and maintained a Buy rating.
Bristol-Myers (BMY) Q1 earnings might have gained from strong demand for Eliquis and incremental contribution from newer drugs. Operating expenses might have jumped on broader portfolio-related costs.
In the latest trading session, Bristol-Myers Squibb (BMY) closed at $63.50, marking a -0.5% move from the ... News. 24/7 help. For premium support please call: 800-290-4726 more ways to reach us.